These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34695777)

  • 1. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
    de Lucio H; García-Marín J; Sánchez-Alonso P; García-Soriano JC; Toro MÁ; Vaquero JJ; Gago F; Alajarín R; Jiménez-Ruiz A
    Eur J Med Chem; 2022 Jan; 227():113915. PubMed ID: 34695777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
    Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
    Garnica P; Etxebeste-Mitxeltorena M; Plano D; Moreno E; Espuelas S; Antonio Palop J; Jiménez-Ruiz A; Sanmartín C
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127371. PubMed ID: 32738977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.
    Baquedano Y; Alcolea V; Toro MÁ; Gutiérrez KJ; Nguewa P; Font M; Moreno E; Espuelas S; Jiménez-Ruiz A; Palop JA; Plano D; Sanmartín C
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3802-12. PubMed ID: 27067328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.
    Baiocco P; Poce G; Alfonso S; Cocozza M; Porretta GC; Colotti G; Biava M; Moraca F; Botta M; Yardley V; Fiorillo A; Lantella A; Malatesta F; Ilari A
    ChemMedChem; 2013 Jul; 8(7):1175-83. PubMed ID: 23733388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
    Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
    Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
    Ruiz-Santaquiteria M; de Castro S; Toro MA; de Lucio H; Gutiérrez KJ; Sánchez-Murcia PA; Jiménez MÁ; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2018 Apr; 149():238-247. PubMed ID: 29501944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Leishmanicidal Activity of Novel Urea, Thiourea, and Selenourea Derivatives of Diselenides.
    Díaz M; de Lucio H; Moreno E; Espuelas S; Aydillo C; Jiménez-Ruiz A; Toro MÁ; Gutiérrez KJ; Martínez-Merino V; Cornejo A; Palop JA; Sanmartín C; Plano D
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase.
    Etxebeste-Mitxeltorena M; Plano D; Espuelas S; Moreno E; Aydillo C; Jiménez-Ruiz A; Soriano JCG; Sanmartín C
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
    Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
    Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
    Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
    Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of L. infantum trypanothione synthetase inhibitors with leishmanicidal activity from a (non-biased) in-house chemical library.
    Alcón-Calderón M; de Lucio H; García-Soriano JC; Revuelto A; de Castro S; López-Gutiérrez C; San-Félix A; Quesada E; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 243():114675. PubMed ID: 36075146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.
    de Lucio H; Revuelto A; Carriles AA; de Castro S; García-González S; García-Soriano JC; Alcón-Calderón M; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 244():114878. PubMed ID: 36332553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3-chloro-6-nitro-1
    Mohamed Abdelahi MM; El Bakri Y; Lai CH; Subramani K; Anouar EH; Ahmad S; Benchidmi M; Mague JT; Popović-Djordjević J; Goumri-Said S
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):151-167. PubMed ID: 34894940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.
    de Lucio H; Toro MA; Camarasa MJ; Velázquez S; Gago F; Jiménez-Ruiz A
    Br J Pharmacol; 2020 Nov; 177(22):5163-5176. PubMed ID: 32888319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase.
    Revuelto A; Ruiz-Santaquiteria M; de Lucio H; Gamo A; Carriles AA; Gutiérrez KJ; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    ACS Infect Dis; 2019 Jun; 5(6):873-891. PubMed ID: 30983322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis.
    Shukla AK; Patra S; Dubey VK
    Mol Cell Biochem; 2011 Jun; 352(1-2):261-70. PubMed ID: 21359528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Dimerization Disruption of
    Revuelto A; de Lucio H; García-Soriano JC; Sánchez-Murcia PA; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    J Med Chem; 2021 May; 64(9):6137-6160. PubMed ID: 33945281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.